179 related articles for article (PubMed ID: 38246959)
21. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
[TBL] [Abstract][Full Text] [Related]
22. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.
Feng X; Lin J; Xing S; Liu W; Zhang G
BMC Cancer; 2017 Jan; 17(1):90. PubMed ID: 28143425
[TBL] [Abstract][Full Text] [Related]
23. Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer.
Wang QQ; Zhou L; Qin G; Tan C; Zhou YC; Yao SK
World J Gastroenterol; 2023 Oct; 29(37):5313-5326. PubMed ID: 37899785
[TBL] [Abstract][Full Text] [Related]
24. Serum CNPY2 isoform 2 represents a novel biomarker for early detection of colorectal cancer.
Peng J; Ou Q; Pan Z; Zhang R; Zhao Y; Deng Y; Lu Z; Zhang L; Li C; Zhou Y; Guo J; Wan D; Fang Y
Aging (Albany NY); 2018 Aug; 10(8):1921-1931. PubMed ID: 30070972
[TBL] [Abstract][Full Text] [Related]
25. Synergistic diagnostic value of circulating tumor cells and tumor markers CEA/CA19-9 in colorectal cancer.
Cai M; He H; Hong S; Weng J
Scand J Gastroenterol; 2023 Jan; 58(1):54-60. PubMed ID: 35968572
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer.
Ma Y; Zhang Y; Bi Y; He L; Li D; Wang D; Wang M; Wang X
Medicine (Baltimore); 2022 Sep; 101(37):e30787. PubMed ID: 36123861
[TBL] [Abstract][Full Text] [Related]
27. Serum SYPL1 is a promising diagnostic biomarker for colorectal cancer.
Liu L; He Q; Li Y; Zhang B; Sun X; Shan J; Pan B; Zhang T; Zhao Z; Song X; Guo Y
Clin Chim Acta; 2020 Oct; 509():36-42. PubMed ID: 32502495
[TBL] [Abstract][Full Text] [Related]
28. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y
Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311
[TBL] [Abstract][Full Text] [Related]
29. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1.
Nielsen HJ; Christensen IJ; Brünner N
Scand J Gastroenterol; 2010; 45(2):200-7. PubMed ID: 20095885
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
Zhang SY; Lin M; Zhang HB
Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer.
Ren G; Li R; Zheng G; Du K; Dan H; Wu H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
Sci Rep; 2023 Dec; 13(1):22830. PubMed ID: 38129505
[TBL] [Abstract][Full Text] [Related]
32. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer.
Rao H; Wu H; Huang Q; Yu Z; Zhong Z
Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865243
[TBL] [Abstract][Full Text] [Related]
33. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
[TBL] [Abstract][Full Text] [Related]
34. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
[TBL] [Abstract][Full Text] [Related]
36. Enhanced prognostic value of combined circulating tumor cells and serum carcinoembryonic antigen in patients with colorectal cancer.
Yang CY; Lin CC; Huang SC; Lu RH; Lo LC; Tseng JY; Tung CY; Lin CH; Jiang JK
J Chin Med Assoc; 2023 May; 86(5):465-471. PubMed ID: 36821465
[TBL] [Abstract][Full Text] [Related]
37. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.
Ferroni P; Roselli M; Spila A; D'Alessandro R; Portarena I; Mariotti S; Palmirotta R; Buonomo O; Petrella G; Guadagni F
Cancer; 2010 Jun; 116(12):2913-21. PubMed ID: 20336782
[TBL] [Abstract][Full Text] [Related]
38. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
